These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1015 related articles for article (PubMed ID: 22789542)

  • 1. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2.
    Schlacher K; Wu H; Jasin M
    Cancer Cell; 2012 Jul; 22(1):106-16. PubMed ID: 22789542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
    Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
    Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
    Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
    EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability.
    Liu W; Polaczek P; Roubal I; Meng Y; Choe WC; Caron MC; Sedgeman CA; Xi Y; Liu C; Wu Q; Zheng L; Masson JY; Shen B; Campbell JL
    Nucleic Acids Res; 2023 Sep; 51(17):9144-9165. PubMed ID: 37526271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CtIP mediates replication fork recovery in a FANCD2-regulated manner.
    Yeo JE; Lee EH; Hendrickson EA; Sobeck A
    Hum Mol Genet; 2014 Jul; 23(14):3695-705. PubMed ID: 24556218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
    Godthelp BC; Wiegant WW; Waisfisz Q; Medhurst AL; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Feb; 594(1-2):39-48. PubMed ID: 16154163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLFN11 promotes stalled fork degradation that underlies the phenotype in Fanconi anemia cells.
    Okamoto Y; Abe M; Mu A; Tempaku Y; Rogers CB; Mochizuki AL; Katsuki Y; Kanemaki MT; Takaori-Kondo A; Sobeck A; Bielinsky AK; Takata M
    Blood; 2021 Jan; 137(3):336-348. PubMed ID: 32735670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi-Anemia-Associated Mutations Destabilize RAD51 Filaments and Impair Replication Fork Protection.
    Zadorozhny K; Sannino V; Beláň O; Mlčoušková J; Špírek M; Costanzo V; Krejčí L
    Cell Rep; 2017 Oct; 21(2):333-340. PubMed ID: 29020621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.
    Raghunandan M; Chaudhury I; Kelich SL; Hanenberg H; Sobeck A
    Cell Cycle; 2015; 14(3):342-53. PubMed ID: 25659033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer and Fanconi anemia: what are the connections?
    Zdzienicka MZ; Arwert F
    Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RADX Modulates RAD51 Activity to Control Replication Fork Protection.
    Bhat KP; Krishnamoorthy A; Dungrawala H; Garcin EB; Modesti M; Cortez D
    Cell Rep; 2018 Jul; 24(3):538-545. PubMed ID: 30021152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery.
    Raghunandan M; Yeo JE; Walter R; Saito K; Harvey AJ; Ittershagen S; Lee EA; Yang J; Hoatlin ME; Bielinsky AK; Hendrickson EA; Schärer O; Sobeck A
    Hum Mol Genet; 2020 May; 29(7):1083-1095. PubMed ID: 31628488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
    Kim TM; Son MY; Dodds S; Hu L; Hasty P
    Mutat Res; 2014; 766-767():66-72. PubMed ID: 25847274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
    Kim TM; Son MY; Dodds S; Hu L; Hasty P
    Mutat Res; 2014; 766-767():66-72. PubMed ID: 25773776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The
    Kolinjivadi AM; Sankar H; Choudhary R; Tay LS; Tan TZ; Murata-Kamiya N; Voon DC; Kappei D; Hatakeyama M; Krishnan V; Ito Y
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the link between MORF4L1 and risk of breast cancer.
    Martrat G; Maxwell CM; Tominaga E; Porta-de-la-Riva M; Bonifaci N; Gómez-Baldó L; Bogliolo M; Lázaro C; Blanco I; Brunet J; Aguilar H; Fernández-Rodríguez J; Seal S; Renwick A; Rahman N; Kühl J; Neveling K; Schindler D; Ramírez MJ; Castellà M; Hernández G; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Davidson R; Ong KR; Cook J; Douglas F; Hodgson S; Brewer C; Morrison PJ; Porteous M; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Pasini B; Ottini L; Putignano AL; Savarese A; Bernard L; Radice P; Healey S; Spurdle A; Chen X; Beesley J; ; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Asperen CJ; Bodmer D; Ausems MG; van Os TA; Blok MJ; Meijers-Heijboer HE; Hogervorst FB; ; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; ; Harbst K; Borg A; Rantala J; Barbany-Bustinza G; Ehrencrona H; Stenmark-Askmalm M; Kaufman B; Laitman Y; Milgrom R; Friedman E; Domchek SM; Nathanson KL; Rebbeck TR; Johannsson OT; Couch FJ; Wang X; Fredericksen Z; Cuadras D; Moreno V; Pientka FK; Depping R; Caldés T; Osorio A; Benítez J; Bueren J; Heikkinen T; Nevanlinna H; Hamann U; Torres D; Caligo MA; Godwin AK; Imyanitov EN; Janavicius R; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Ferrer SF; Collonge-Rame MA; Mortemousque I; McGuffog L; Chenevix-Trench G; Pereira-Smith OM; Antoniou AC; Cerón J; Tominaga K; Surrallés J; Pujana MA
    Breast Cancer Res; 2011 Apr; 13(2):R40. PubMed ID: 21466675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.
    Kolinjivadi AM; Sannino V; De Antoni A; Zadorozhny K; Kilkenny M; Técher H; Baldi G; Shen R; Ciccia A; Pellegrini L; Krejci L; Costanzo V
    Mol Cell; 2017 Sep; 67(5):867-881.e7. PubMed ID: 28757209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
    Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
    J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isomerization of BRCA1-BARD1 promotes replication fork protection.
    Daza-Martin M; Starowicz K; Jamshad M; Tye S; Ronson GE; MacKay HL; Chauhan AS; Walker AK; Stone HR; Beesley JFJ; Coles JL; Garvin AJ; Stewart GS; McCorvie TJ; Zhang X; Densham RM; Morris JR
    Nature; 2019 Jul; 571(7766):521-527. PubMed ID: 31270457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.